Literature DB >> 25593536

Benefits and limitations of multimodality imaging in the diagnosis of a primary cardiac lymphoma.

Prabhjot Singh Nijjar, Sofia Carolina Masri, Ashenafi Tamene, Helina Kassahun, Kenneth Liao, Uma Valeti.   

Abstract

Primary cardiac tumors are far rarer than tumors metastatic to the heart. Angiosarcoma is the primary cardiac neoplasm most frequently detected; lymphomas constitute only 1% of primary cardiac tumors. We present the case of a 55-year-old woman with a recently diagnosed intracardiac mass who was referred to our institution for consideration of urgent orthotopic heart transplantation. Initial images suggested an angiosarcoma; however, a biopsy specimen of the mass was diagnostic for diffuse large B-cell lymphoma. The patient underwent chemotherapy rather than surgery, and she was asymptomatic 34 months later. We use our patient's case to discuss the benefits and limitations of multiple imaging methods in the evaluation of cardiac masses. Certain features revealed by computed tomography, cardiac magnetic resonance, and positron emission tomography can suggest a diagnosis of angiosarcoma rather than lymphoma. Cardiac magnetic resonance and positron emission tomography enable reliable distinction between benign and malignant tumors; however, the characteristics of different malignant tumors can overlap. Despite the great usefulness of multiple imaging methods for timely diagnosis, defining the extent of spread and the hemodynamic impact, and monitoring responses to treatment, we think that biopsy analysis is still warranted in order to obtain a correct histologic diagnosis in cases of suspected malignant cardiac tumors.

Entities:  

Keywords:  Diagnostic imaging/methods; heart neoplasms/diagnosis/pathology/radiography; lymphoma/diagnosis/radiography; treatment outcome

Mesh:

Substances:

Year:  2014        PMID: 25593536      PMCID: PMC4251343          DOI: 10.14503/THIJ-13-3595

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  5 in total

1.  Primary cardiac sarcomas.

Authors:  J B Putnam; M S Sweeney; R Colon; L A Lanza; O H Frazier; D A Cooley
Journal:  Ann Thorac Surg       Date:  1991-06       Impact factor: 4.330

Review 2.  Primary cardiac tumors.

Authors:  Monika J Leja; Dipan J Shah; Michael J Reardon
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  CT and MR imaging of primary cardiac malignancies.

Authors:  P A Araoz; H E Eklund; T J Welch; J F Breen
Journal:  Radiographics       Date:  1999 Nov-Dec       Impact factor: 5.333

Review 4.  Clinical perspectives of primary cardiac lymphoma.

Authors:  Ramesh M Gowda; Ijaz A Khan
Journal:  Angiology       Date:  2003 Sep-Oct       Impact factor: 3.619

5.  Primary cardiac tumors.

Authors:  N A Silverman
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

  5 in total
  4 in total

1.  High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.

Authors:  Shin Lee; Takahiro Yamauchi; Keiichi Kinoshita; Shin Imamura; Kenichi Kamiya
Journal:  J Clin Exp Hematop       Date:  2017-09-06

2.  Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor.

Authors:  Baljit Singh; Randy Ip; Ahmed Ibrahim Al-Rajjal; Zyad Kafri; Ayad Al-Katib; Tarik Hadid
Journal:  Case Rep Cardiol       Date:  2016-12-07

3.  Case report: Primary cardiac angiosarcoma with multiple metastases.

Authors:  Xuan Li; Lan Lan; Huijuan Hu
Journal:  Front Cardiovasc Med       Date:  2022-07-28

4.  Syncope and Cardiac Tamponade: Multimodality Imaging of Primary Cardiac Lymphoma.

Authors:  Virginia Serra; Francesco De Luca; Ketty Savino; Maurizio Del Pinto; Claudia Castellani; Paola Fiaschini; Laura Tomasello; Claudio Cavallini
Journal:  J Cardiovasc Echogr       Date:  2021-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.